GCG Deal Announcement | Mirus Capital Advisors advised Oxipit
Mirus Capital Advisors advised Oxipit on its sale to Sectra.
Based in Vilnius, Lithuania and founded in 2017, Oxipit holds the first CE Class IIB certification for autonomous AI in chest X-ray analysis. Its ChestLink solution automatically identifies high-confidence normal examinations and removes them from the radiologist’s worklist, enabling specialists to focus on cases that require their clinical judgment.
Sectra is an international medical imaging IT and cybersecurity company headquartered in Linköping, Sweden.
The transaction was led by Brendan Kiernan, Alan Fullerton and Jason Arican. Read more here.
/https://storage.googleapis.com/ggi-backend-prod/public/media/7901/MIRUS_Logo-sq.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/7900/MIRUS_Logo-2026.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/7846/gcg_capital_landscape_pure.jpg)
/https://storage.googleapis.com/ggi-backend-prod/public/media/7892/Untitled-design-(7).png)
/https://storage.googleapis.com/ggi-backend-prod/public/media/5140/LOGO-SQUARE-Website-Hyde-Park.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5777/Delphi-Advisors_Logo_sq.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5150/LOGO-SQUARE-Website-Statesman-Business-Advisors,-LLC.png){kind=logo}